Anti-CLEC16A [4F11] monoclonal antibody
Invented at The University of British Columbia
- Datasheet
- References (1)
- Inventor Info
Info
Catalogue Number | 157893 |
Applications | ELISA WB |
Antigen/Gene or Protein Targets | C-Type Lectin Domain Containing 16A |
Synonyms | CLEC16A (also known as KIAA0350) |
Reactivity | Human |
Relevance |
antibody against CLEC16A (specifically binds to C-terminal human peptide CLEC16A954-980: VIVNETEADSKPSKNVARSAAVETASL) CLEC16A is a cytosolic protein which is differentially expressed in human immune cells and is known to be highly expressed on B-lymphocytes, natural killer (NK) and dendritic cells. CLEC16A gene has been linked to several autoimmune diseases, including Addison's disease, diabetes melllitus, Crohn's disease, primary biliary cirrhosis, juvenile idiopathic arthritis, rheumatoid arthritis and multiple sclerosis. . CLEC16A has been shown to regulate various immune pathways including directly regulating leukocyte antigen class II pathway in antigen presenting cells, autophagy, mitophagy, and NK cell cytotoxicity. |
Immunogen | 27-mer C-terminal human peptide (CLEC16A 954-980: VIVNETEADSKPSKNVARSAAVETASL) linked to KLH |
Positive Control | IgG2B |
Research Area | Autoimmunity, Diabetes, Immunology, Neurobiology |